Karma Biotechnologies Revenue and Competitors
Estimated Revenue & Valuation
- Karma Biotechnologies's estimated annual revenue is currently $2.5M per year.
- Karma Biotechnologies's estimated revenue per employee is $155,000
Employee Data
- Karma Biotechnologies has 16 Employees.
- Karma Biotechnologies grew their employee count by -6% last year.
Karma Biotechnologies's People
Name | Title | Email/Phone |
---|---|---|
1 | Cofounder and CEO | Reveal Email/Phone |
2 | President, Chief Financial Officer & Chief Business Officer | Reveal Email/Phone |
3 | Associate Director | Reveal Email/Phone |
4 | Associate Director | Reveal Email/Phone |
5 | Principal Scientist | Reveal Email/Phone |
Karma Biotechnologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Karma Biotechnologies?
Therapies for autoimmune diseases are stuck in the 20th century – physicians can only alleviate a patient's symptoms by crippling their entire immune system. Karma was founded by a team of immune engineers, nanotech scientists, and company builders to create a better solution. We're developing Xavines™, off-the-shelf therapeutics designed to shut down only the self-attacking rogue immune cells while leaving the rest of the immune system functional.
keywords:N/AN/A
Total Funding
16
Number of Employees
$2.5M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 16 | -6% | N/A |
#2 | $3.1M | 16 | -6% | N/A |
#3 | $1.4M | 16 | N/A | N/A |
#4 | $1.4M | 16 | N/A | N/A |
#5 | $1.4M | 16 | N/A | N/A |